Using Mirabegron to Increase BP in Patients With POTS
NCT06133075
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Postural Orthostatic Tachycardia Syndrome
Chronic Orthostatic Intolerance
Syncope
Interventions
DRUG:
Mirabegron 50 MG
DRUG:
Mirabegron 25 MG
Sponsor
Cedars-Sinai Medical Center